Skip to content
Medical Health Aged Care, Women

InMode Australia Unveils Cutting-Edge Aesthetic Technologies Leading 2025 Trends

InMode Australia 3 mins read

Introducing QuantumRF: The Next Generation of Skin Tightening

Leading the 2025 aesthetic landscape is InMode's groundbreaking non-suction QuantumRF technology for facial and body treatments.
This advanced fractional bi-polar radiofrequency (RF) treatment safely targets the deep layers of the skin, stimulating collagen production and tightening the skin without the need for incisions or surgery. This treatment is particularly effective for those looking for a single-session minimally invasive treatment to combat sagging skin, reduce fat, and improve fine lines and wrinkles.

What sets QuantumRF apart is its precision and customisable settings, allowing surgeons to tailor the treatment to everyone, regardless of age, gender or skin type.
QuantumRF reduces the challenge of limited theatre time, and can be used in a theatre environment, or as an in-office procedure. It is a sought-after alternative to brachioplasties and thighplasties as there is no cutting or scarring.

According to leading Plastic surgeon, Dr Alfredo Hoyos, this technology is set to become the go-to solution for those seeking a quick, effective, and safer, treatment to achieve youthful, rejuvenated, and firmer skin. With minimal discomfort and downtime, it is expected that QuantumRF will follow the global trend and be widely adopted by aesthetic surgeons throughout Australia.

InMode QuantumRF

Morpheus8 Burst with Scaleä: Revolutionising Skin Rejuvenation and Contouring

Building upon the global success of Morpheus8, InMode introduces Morpheus8 Burst with Scaleä technology. The introduction of the next-generation Morpheus8 Burst and Burst Deep will build on InMode’s industry-leading position for individuals looking for a more dramatic skin-tightening and shaping effect. Minimally invasive, non-surgical and with less downtime and discomfort, this technology will continue to rise in popularity in the new year.

InMode Morpheus8

Looking Ahead: Trends to Watch in 2025

The aesthetic industry is witnessing a significant shift towards treatments that provide natural results with minimal intervention, particularly the rise of rapid weight loss with associated loose skin. InMode's suite of technologies aligns with this trend, emphasising minimally invasive procedures that deliver effective outcomes without extensive downtime and provide the option of having treatments performed in-theatre or in-office. As we progress through 2025, expect to see a growing preference for such treatments, with InMode leading the charge in innovation and patient satisfaction.


About InMode Australia

InMode is a leading global provider of innovative medical aesthetic technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology, light-based applications including IPL and laser, and EMS. InMode strives to enable new emerging non-surgical procedures as well as improving and complimenting existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology and women’s health, and cosmetic clinics. For more information about InMode and its wide array of medical technologies, visit www.inmode.com.au


Key Facts:
  • Key Technologies:
    • QuantumRF: A next-generation, non-suction fractional bi-polar radiofrequency (RF) technology for skin tightening.
      • Stimulates collagen production and tightens skin non-surgically.
      • Effective for sagging skin, fat reduction, fine lines, and wrinkles.
      • Customisable settings for all ages, genders, and skin types.
      • Can be performed in-office or in a theatre setting.
      • Alternative to surgical procedures like brachioplasties and thighplasties, avoiding cutting or scarring.
      • Expected to be widely adopted in Australia for its quick and effective results.
    • Morpheus8 Burst with Scale: An evolution of the globally successful Morpheus8 technology.
      • Offers enhanced skin rejuvenation, tightening, and contouring.
      • Minimally invasive with reduced downtime and discomfort.
      • Expected to gain popularity in 2025.
  • Industry Trends:
    • Growing demand for treatments that provide natural results with minimal intervention.
    • Increased focus on addressing loose skin from rapid weight loss.
    • Shift towards in-office or in-theatre minimally invasive procedures over traditional surgical methods.
  • Company Background:
    • InMode is a global leader in radiofrequency (RF), light-based (IPL, laser), and EMS technologies.
    • Offers solutions across multiple medical fields, including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology and women’s health, and cosmetic clinics.

 


About us:

InMode Australia | RF Machine & Aesthetic Equipment Suppliers


Contact details:

For media inquiries, please contact:

Kate Boissett
Public Relations Manager - InMode Australia
Phone: (02) 7209 5678
Mobile: 0422 734 621
Email:
[email protected]
Website:
www.inmode.com.au
Instagram: @InmodeAustralia

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 11/07/2025
  • 16:28
The Florey

Harnessing mRNA to prevent and slow Alzheimer’s disease

mRNA Victoria funds 2Floreyprojects to prevent and treat Alzheimer’s disease Key points mRNA Victoria has funded 2 Alzheimer’s disease research projects that could position Victoria as a leader in the development of mRNA-based therapies. Dr Abdel Belaidi will develop an mRNA-based system that crosses the blood-brain barrier and aims to slow or even halt disease progression. Dr Rebecca Nisbet will develop an mRNA vaccine that aims to prevent Alzheimer’s disease from developing. Florey researchers working at the cutting edge of dementia research have received funding from mRNA Victoria to develop treatments and a vaccine for Alzheimer’s disease. Since mRNA vaccines…

  • Medical Health Aged Care
  • 11/07/2025
  • 07:05
Royal Australian College of GPs

GPs urge Tasmanian families to get vaccinated against whooping cough and call for free shots to reduce barriers

The Royal Australian College of GPs (RACGP) is urging Tasmanian families to get vaccinated against pertussis, or ‘whooping cough’ and called on all parties and candidates running in the state election to commit to making the vaccination free for all patients. From 1 January 2024 to April 2025, 1238 whooping cough cases were notified in Tasmania, including 10 infants aged under six months. Most hospitalisations and deaths occur in this group, who are not old enough to have received all vaccine doses. More than 21,000 infections were recorded nationwide last year, compared to just 2450 in 2023, and the National…

  • Contains:
  • General News, Medical Health Aged Care
  • 11/07/2025
  • 07:00
La Trobe University

La Trobe researchers awarded $4.5 million in ARC Future Fellowships

LaTrobe University researchers have secured almost $4.5 million in Federal Government funding to further studies into areas such as immune cell development, Australian history and agriculture. Four researchers received an Australian Research Council (ARC) Future Fellowship 2025. The prestigious Future Fellowships support high quality research in areas of national and international benefit, including in national research priorities. Dr Lisa Mielke, from the School of Cancer Medicine, the La Trobe Institute of Molecular Science (LIMS) and the Olivia Newton-John Cancer Research Institute (ONJCRI), received $1.13 million to identify new molecules for future drug and vaccine development to improve gut health in…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.